$ALKEM

$ALKEM Alkem Laboratories is currently trading around ₹5,598 (10 Aug 2026 close), versus a 52-week range of ₹4,738–₹5,934. So the stock is trading close to its 52-week high. 📊 Fundamental picture FY26 was strong: Q4 FY26 revenue: ₹3,603 Cr, +14.6% YoY EBITDA: ₹517 Cr, +32.2% YoY EBITDA margin improved to 14.4% from 12.4% PBT before exceptional items: +40.7% International business grew 25.4% in Q4 Management expects FY27 to continue benefiting from chronic therapies and international launches. The important point is that profitability is growing faster than revenue, which indicates operating leverage and improving business mix. 📈 Technical view At around ₹5,600, the stock is in a strong long-term uptrend, but it is also near its 52-week high, so chasing at current levels carries higher risk. For the current week, technical levels reported around the stock are: Support: ₹5,490–₹5,500 Immediate resistance: ₹5,760 Major resistance: ₹5,900–₹5,935 Above ₹5,935 → potential fresh breakout Below ₹5,490 → momentum can weaken.